Recent Company News

• 01:43 PM ET Mar 30, 2026
  

  Meiji Seika Pharma invests in Centivax to develop next-generation universal vaccine platform (¥3878.0000, 0)

• 01:09 PM ET Mar 30, 2026
  

  StreetAccount Summary - Private company transactions for the week ended 28-Mar

• 02:45 AM ET Mar 25, 2026
  

  Meiji lowers FY net income attributable guidance to ¥36.50B vs prior guidance ¥54.00B and FactSet ¥55.06B [6 est, ¥52.60-58.80B] (¥3950.0000, 0)

• 03:44 AM ET Mar 18, 2026
  

  Japan February estimated foreign visitor arrivals 3.5M, +6.4% y/y

• 11:37 PM ET Mar 16, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (46 total)

• 10:40 PM ET Mar 16, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (27 total)

• 08:06 PM ET Mar 02, 2026
  

  Meiji Seika Pharma's morcamilast receives orphan medicinal product designation by European Commission for treatment of palmoplantar pustulosis

• 11:13 PM ET Mar 01, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (172 total)

• 10:20 PM ET Mar 01, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (149 total)

• 11:27 PM ET Feb 26, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (151 total)